SLC7A11 and diabetes mellitus: These findings suggest that reduced SLC7A11 expression may represent a common molecular signature in both PD and DM, potentially contributing to the increased susceptibility of diabetic patients to PD‐related neurodegeneration through impaired redox homeostasis and increased ferroptosis sensitivity.